OpenEvidence America's Official Medical Knowledge Platform OpenEvidence is the leading medical platform for healthcare professionals, featuring answers grounded in peer-reviewed research from NEJM, JAMA, NCCN, Cochrane, and more
About | OpenEvidence America's Official Medical Knowledge Platform OpenEvidence is the leading medical platform for healthcare professionals, featuring answers grounded in peer-reviewed research from NEJM, JAMA, NCCN, Cochrane, and more
National Organization for Rare Disorders and OpenEvidence Partner to . . . NORWELL, Mass , and MIAMI, Fla (March 12, 2026) - The National Organization for Rare Disorders (NORD®) and OpenEvidence today announced a new partnership to expand access to trusted, expert-reviewed rare disease information for clinicians, patients and families
Announcements - OpenEvidence America's Official Medical Knowledge Platform OpenEvidence is the leading medical platform for healthcare professionals, featuring answers grounded in peer-reviewed research from NEJM, JAMA, NCCN, Cochrane, and more
OpenEvidence and Veeva Announce Long Term Partnership MIAMI, FL and PLEASANTON, CA — Oct 16, 2025 — OpenEvidence and Veeva Systems (NYSE: VEEV) today announced the formation of a long-term partnership to jointly create and market Open Vista
OpenEvidence 2. 0 Now Available We are excited to announce OpenEvidence 2 0 In addition to medical search, OpenEvidence now fully supports administrative and clinical workflow use cases, including:
The American Diabetes Association and OpenEvidence Collaborate to . . . ARLINGTON, VA (Dec 3, 2025)— Today, the American Diabetes Association® (ADA) announced a collaboration with OpenEvidence, an AI platform delivering evidence-grounded answers to more than 500,000 U S health care professionals, to offer improved access to the ADA’s Standards of Care in Diabetes (Standards of Care)
NCCN and OpenEvidence Collaborate to Bring Clinical Oncology Guidelines . . . PLYMOUTH MEETING, PA, and MIAMI, FL — Nov 5, 2025 — The National Comprehensive Cancer Network® (NCCN®) and OpenEvidence, the leading AI-powered medical search and decision-support platform, today announced a licensing agreement to make NCCN’s trusted, evidence-based oncology guidelines accessible through OpenEvidence’s medical artificial intelligence technology Through this
Mount Sinai Health System Collaborates with OpenEvidence to Provide . . . Implementing OpenEvidence provides our pharmacists, nurses, and physicians with a unified, trusted platform for evidence-based decision-making, reinforcing our mission to lead the way in safe and effective clinical AI," said Nicholas Gavin, Vice President, Chief Clinical Innovation Officer of Mount Sinai Health System
OpenEvidence, the Fastest-Growing Application for Physicians in History . . . OpenEvidence helps clinicians make high-stakes clinical decisions at the point of care OpenEvidence is redefining evidence-based medicine in real-time and transforming how frontline healthcare providers access, evaluate, and apply the world's medical knowledge OpenEvidence is actively used across more than 10,000 hospitals and medical centers nationwide and by more than 40% of physicians in